News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Filippo Alongi: Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification
grmedcenter.com
Dec 30, 2024, 11:16

Filippo Alongi: Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification

Filippo Alongi, Chairman of Advanced Radiation Oncology, shared a post on X:

“12 international centres, 1028 patients:

-Preop RT dose boost in rectal cancer increase pCR rate particularly in T3-4 operated over week 11.
-Preop RT dose boost minimally but significantly increase acute toxicity.”

Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I

Authors: Luca Nicosia, Marco Lorenzo Bonù, Ilaria Angelicone, Gianluigi Lunardi, Rita Marina Niespolo, Micol Zannetti, Linda Agolli, Giuditta Chiloiro, Angela Romano, Fatemeh Jafari, Mahdi Aghili, Reza Ghalehtaki, Giampaolo Montesi, Francesca De Felice, Filippo De Renzi, Alessandro Magli, Jennifer Le Guevelou, Marco Lupattelli, Giuseppe Minniti, Maria Antonietta Gambacorta, Daniel Habermehl, Pierfrancesco Franco, Stefano Arcangeli, Michela Buglione, Filippo Alongi, Mattia Falchetto Osti.

Filippo Alongi

acute toxicity Alessandro Magli Angela Romano cancer Daniel Habermehl Fatemeh Jafari Filippo Alongi Filippo De Renzi Francesca De Felice Giampaolo Montesi Gianluigi Lunardi Giuditta Chiloiro Giuseppe Minniti Ilaria Angelicone Jennifer Le Guevelou Linda Agolli Luca Nicosia Mahdi Aghili Marco Lorenzo Bonù Marco Lupattelli Maria Antonietta Gambacorta Mattia Falchetto Osti Michela Buglione Micol Zannetti OncoDaily Oncology Pierfrancesco Franco rectal cancer Reza Ghalehtaki Rita Marina Niespolo RT dose Stefano Arcangeli
Special Coverage
Insight
Dec 30, 2024, 11:16
Filippo Alongi: Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification
Societies
Dec 30, 2024, 10:56
“QI Scholar Nursing Presentations Part 1” from the SIOP Nursing Network
Insight
Dec 30, 2024, 10:54
Raul Cordoba: Early progression beyond first-line chemoimmunotherapy in follicular lymphoma by Alberto Bavieri et al.
Blog
Dec 30, 2024, 10:51
A massive turnout for the free cancer screening event by NCI of Kenya and Bongaa Health Foundation - NCI of Kenya
Blog
Dec 30, 2024, 10:48
Rahul Banerjee: Fascinating work by Noopur Raje et al looking at visceral EMD in Multiple Myeloma
Blog
Dec 30, 2024, 10:45
The report of "Girem Full!" 2024: The power of books to fight cancer - IDIBAPS
Blog
Dec 30, 2024, 10:05
Translational genomics and targeted therapies in solid tumours - August Pi i Sunyer Biomedical Research Institute
Science
Dec 30, 2024, 08:49
Alessio Cortellini: Strength lies in collaboration
Science
Dec 30, 2024, 08:35
Are PPIs beneficial or harmful for stress ulcer prophylaxis in mechanically ventilated patients? - NEJM Group
Blog
Dec 30, 2024, 07:41
Antonio M. Grimaldi: Next Generation Sequencing diagnostics will soon be available at San Giovanni Addolorata Hospital, Benevento
Blog
Dec 30, 2024, 07:37
Douglas Flora: Deeply inspired by the progress made at St. Elizabeth Healthcare
Blog
Dec 30, 2024, 07:34
National Center for Cancer Immune Therapy of Denmark at ESMO Immuno-Oncology Congress 2024